Zobrazeno 1 - 10
of 11
pro vyhledávání: '"TB Rodriguez-Cuadros"'
Publikováno v:
Clinical pharmacy.
Background Healthy skin around an open stoma in colostomy patients is exposed to a humid environment and the acidity of the faeces. This condition can produce periostomal skin problems such as very painful ulcers, with difficult pain management. Chit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33891154bad1ca988d9350dfd55bc959
https://doi.org/10.1136/ejhpharm-2017-000640.36
https://doi.org/10.1136/ejhpharm-2017-000640.36
Publikováno v:
Production and preparation.
Background Decitabine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (AML) de novo or secondary, according to the classification of the WHO, who are not candidates for conventional induction chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5de4fba705492b1e7daff416343b03b
https://doi.org/10.1136/ejhpharm-2017-000640.456
https://doi.org/10.1136/ejhpharm-2017-000640.456
Publikováno v:
Production and preparation.
Background The use of topical 2% aqueous eosin in the treatment of periostomal dermatitis with varying degrees of injury has recently been reported in the literature, but the presence of periostomal ulcer is difficult to cure with eosin. Allantoin ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4b78779f7a66d9fa57040816e1c12fa
https://doi.org/10.1136/ejhpharm-2017-000640.458
https://doi.org/10.1136/ejhpharm-2017-000640.458
Publikováno v:
General management.
Background The use of citalopram and escitalopram has been associated with QT interval prolongation. Therefore, AEMPS published an alert in October 2011, recommending that the highest dose used in patients with liver dysfunction and patients >65 year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf5774944f832088f9ed3b0e0038a41d
https://doi.org/10.1136/ejhpharm-2017-000640.350
https://doi.org/10.1136/ejhpharm-2017-000640.350
Publikováno v:
Drug information and pharmacotherapy.
Background Toxic epidermal necrolysis (TEN) is a rare immune mediated life threatening reaction for which drugs account for more than 95% of cases. The incidence of TEN is 0.4–1.2 cases per million population per year. TEN are more commonly caused
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::108ba34808ead744ba52edcfd98786da
https://doi.org/10.1136/ejhpharm-2017-000640.267
https://doi.org/10.1136/ejhpharm-2017-000640.267
Publikováno v:
Production and preparation.
Background Infants will likely encounter a diaper rash (DR) in the first years of life. There are common ointments used in the topical treatment of ulcerative skin lesions such as DR in neonates—namely, hydrocortisone cream (1%), zinc oxide and eos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b60115275fed1a3d1d00f38796ecb582
https://doi.org/10.1136/ejhpharm-2017-000640.457
https://doi.org/10.1136/ejhpharm-2017-000640.457
Publikováno v:
European Journal of Hospital Pharmacy. 23:A124.2-A124
Background Evidence of the efficacy of omalizumab for mast cell activation disease (MCAD) has been collected from only a few case series and isolated cases. It is not approved for this indication in the USA or Europe. Purpose To describe omalizumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6414169fb59ebdfe0d0355ef92f16725
https://doi.org/10.1136/ejhpharm-2016-000875.282
https://doi.org/10.1136/ejhpharm-2016-000875.282
Publikováno v:
European Journal of Hospital Pharmacy. 23:A124.1-A124
Background Fingolimod represents a new class of treatment for patients with relapsing remitting multiple sclerosis (RRMS) because it allows oral administration and it also has a mechanism of action that targets not only the immune system but also neu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bc31c23da5bafe56e69b1681a588ddd
https://doi.org/10.1136/ejhpharm-2016-000875.281
https://doi.org/10.1136/ejhpharm-2016-000875.281
Publikováno v:
European Journal of Hospital Pharmacy. 23:A123.3-A124
Background For a pregnant woman and her child, untreated tuberculosis (TB) involves a higher risk than the treatment itself. While the drugs used in the initial treatment of tuberculosis cross the placenta, they do not appear to have harmful effects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e73a5d1c6ae55bb0967b8c1e27ab6af6
https://doi.org/10.1136/ejhpharm-2016-000875.280
https://doi.org/10.1136/ejhpharm-2016-000875.280
Publikováno v:
European Journal of Hospital Pharmacy. 23:A197.1-A197
Background An alternative liquid sevoflurane for vascular ulcers has recently been reported in the literature. Innovative topical application of this halogenated anaesthetic for management of analgesia appears to be successful. The selection of dimet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36cc9bea459b3f8683ffc0075477e4d9
https://doi.org/10.1136/ejhpharm-2016-000875.445
https://doi.org/10.1136/ejhpharm-2016-000875.445